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Abstract
Purpose MegaCell DCS, an animal product-free culture
medium formulated for storing corneas, is superior to the
traditionally used MEM (Eagle’s) with Earles salts, Hepes,
and supplemented with foetal calf serum (2 %), glutamine
and an antibiotic cocktail (EB MEM). Because this medium
does not prevent corneal swelling, and Dextran T500, which
is traditionally used for reversing this process before trans-
plant may have adverse effects on corneas, the purpose of
the current investigation was to identify an alternative poly-
mer that is compatible with MegaCell DCS.
Methods Corneas maintained in MegaCell DCS or EB
MEM were transferred to either EB MEM 5 % Dextran
T500 or MegaCell DCS containing 5 % Dextran T500,
4 % polyethylene glycol (PEG) 10,000, PEG 35,000 (2 %,
3 %, 4 %) or Poloxamer 188 (4 %). Endothelial cell losses
were determined and corneal hydration levels measured.
Stromal cell cultures were generated and immunostained
with anti α-SMA antibody. Janus Green was used to com-
pare the viability of endothelial cells of corneas maintained
in MegaCell DCS and EB MEM and respectively thinned
with PEG 35,000 and Dextran T500.
Results The rates of endothelial cell loss from corneas held
in MegaCell DCS and thinned in MegaCell DCS containing
5 % Dextran T500, 4 % PEG 10,000 and 4 % Poloxamer
188 for 6 days were similar. When explants of these corneas
were cultured myofibroblasts were generated. Although at
concentrations of 4 % (w/v) both PEG 10,000 and
Poloxamer 188 caused excessive dehydration, the hydration
levels of corneas held in MegaCell DCS containing 3 %
PEG 35,000 were similar to those of corneas held in EB
MEM 5% Dextran T500. Endothelial cell losses after 6 days
were negligible, explants of the corneas generated uniform
fibroblastic stromal cell cultures and the extents of Janus
Green staining were similar. Over 20 days the inclusion of
5 % Dextran T500 in EB MEM but not 3 % PEG 35,000 in
MegaCell DCS, increased the rate of endothelial cell loss.
Conclusion PEG 35,000 at a concentration of 3 %w/v does
not induce endothelial cell loss and is compatible with
MegaCell DCS for thinning corneas prior to transplantation.
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Introduction
The primary function of corneal endothelia is to passively
transport nutrients and solutes from the aqueous humour to
the more superficial layers, and simultaneously actively
pump water from the stroma into the aqueous. Although
these activities are coordinated in vivo to maintain the
slightly dehydrated state required for optical transparency,
in culture corneas swell, possibly as a result of the shutting
down of their endothelial cell Na+/K+ ATPase pumps and
the loss of several layers of epithelium. For this reason, to
facilitate suturing and post-operative recovery, almost all
organ cultured corneas stored in European Eye Banks are
thinned in medium containing the polyglucose polymer,
Dextran T500, prior to transplant [1, 2].
Despite the widespread use of Dextran T500, there are
reservations over its toxicity. Initial observations of Van der
Want and Pels [3], showing that corneas placed in medium
containing Dextran T500 for 7 days accumulated dextran in
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almost all cellular components, have been corroborated by
Redbrake et al. [4]. In addition to observing both intra- and
extracellular deposits throughout the cornea, these authors
noted that intracellular dextran accumulated after only 1 day
and a significant amount of extracellular dextran was insol-
uble. Other authors have reported that concomitant with the
accumulation of dextran, the loss of endothelial cells in-
creased significantly from a base level of 0.9 % per day in
dextran-free medium to 15 % over a period of 2 days in
media containing dextran [5, 6]. The current consensus of
opinion is that corneas destined for transplant should be left
no longer than 4 days in Dextran T500 [7, 8].
Recently we investigated the suitability of serum-freeMeg-
aCell™MEM and an animal product-free medium (MegaCell
DCS) for storing corneas. Relative to EB MEM [Minimum
Essential Medium (Eagle’s) with Earles salts, 25 mM Hepes,
supplemented with glutamine (20 mM) and foetal calf serum
(2 %v/v)] which is widely used for storing corneas in Euro-
pean Eye Banks [9], these media prolonged the viability of
corneal endothelial cells and improved their morphological
appearance [10, 11]. The purpose of this study was to identify
and evaluate a thinning agent, other than Dextran T500 that
does not compromise the viability of the corneal endothelium
and is compatible with MegaCell DCS.
Materials and methods
Experimental material
The pairs of corneas used in this investigation had been
granted research permission by the families of the donors
and are listed in Tables 1 and 2. They were obtained from
the Bristol CTS Eye Bank and considered unsuitable for
transplantation because of medical contraindications. The
work undertaken adhered to the tenets of the declaration of
Helsinki and had NHS Research Ethics approval.
Corneal storage
Corneas held under standard eye banking conditions in EB
MEM [MEM containing Earles salts, Hepes (25 mM), and
supplemented with glutamine (Invitrogen Ltd), a penicillin,
streptomycin and amphotericin cocktail (Sigma-Aldrich
Ltd) and 2 % foetal calf serum (FCS, Invitrogen Ltd)], were
transferred to 100 ml din bottles containing either fresh EB
MEM, MegaCell™MEM or MegaCell DCS supplemented
only with the antibiotic cocktail. After incubating for a
minimal period of 3 weeks the corneas were suspended in
60 ml din bottles containing either EB MEM 5 % Dextran
T500 or MegaCell DCS containing 5 % Dextran T500, PEG
10,000 (4 %), PEG 35,000 (2 %, 3 %, 4 %) or Poloxamer
188 (4 %) for 6 days unless otherwise specified.
Corneal endothelial cell density and rate of loss
measurement
As described previously [10], the corneal endothelia were
examined before and during the thinning process under hypo-
tonic sucrose (1.8 %w/v) after staining with trypan blue (0.4 %
w/v, Sigma-Aldrich Ltd). Photographs were taken every other
day. From these, endothelial cell densities were estimated and
plotted against time to determine relative rates of cell loss.
Corneal hydration estimation
Discs (8 mm) were trephined from the centres of the thinned
corneas, blotted dry and placed in small, preweighed petri dishes.
They were then weighed and reweighed after drying at 60 °C to
constant weight. Percentage hydration levels were calculated
from the formula (wet weight – dry weight/wet weight) x 100.
Corneal cell culture
Explants were prepared from corneas that had been stored in
MegaCell DCS and thinned for 6 days in EB MEM Dextran
T500 or MegaCell DCS containing Dextran T500, PEG
10,000, PEG 35,000 or Poloxamer 188. They were placed
in either 25 ml flasks or 6 well plates and incubated under
5 % CO2/95 % air at 36 °C in MegaCell™MEM containing
the antibiotic antimycotic mix and FCS (5 %). After 7 days,
the media was replenished every 3–4 days.
Anti α-SMA antibody immunostaining
Cultures of corneal stromal cells were washed twice with
PBS, fixed with formol saline (10 %v/v) for 20 min at room
temperature, permeabilised with Triton X-100 (0.25 %v/v)
and again rinsed with PBS. They were then sequentially
incubated for 1 h at 36 °C with a mouse anti-human actin
[alpha smooth muscle isoform] monoclonal antibody (Milli-
pore Ltd) diluted 1:500 in PBS containing FCS (5%v/v) and a
1:1000 diluted rhodamine conjugated goat anti-mouse IgG
(Millipore Ltd), The washing solution was PBS/Tween 20
(0.1 %). After a final rinse in PBS, the cultures were photo-
graphed under a Leitz Dialux 22 EB fluorescence microscope.
Primary antibody was omitted from cultures used as controls.
Janus Green staining
A method using Janus Green as a vital stain for assessing the
extent of endothelial cell damage has been reported [12, 13].
For this study, Janus Green B (Sigma Aldrich Ltd) was dis-
solved at a concentration of 1 mg ml-1 in isotonic saline and
filter sterilised. All corneas, with their scleral rim intact, were
placed in small petri dishes, endothelial cell side up. These
were covered with the Janus Green B solution (150 μl) for
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Table 1 Characteristics of the
corneas used to evaluate endo-
thelial cell loss after thinning




1A/B 82 M 9 1690; 1700
2A/B 69 M 11 2160; 2070
3A/B 66 M 15 2330; 2190
4A/B 86 M 12 1300; 1340
5A/B 46 M 11 2390; 2300
6A/B 33 F 10 2510; 2480
7A/B 81 M 8 1980; 2570
8A/B 41 M 12 1570; 1740
9A/B 91 F 12 2360; 1920
10A/B 79 F 8 2250; 2510
11A/B 74 M 7 2570; 2680
12A/B 84 F 2 1420; 1500
13A/B 75 M 4 2710; 2890
14A/B 58 M 13 2300; 2300
15A/B 65 M 13 2120; 2010
16A/B 92 M 1 2240; 2150
17A/B 41 F 5 2680; 2790
18A/B 82 M 11 2630; 2630
19A/B 72 F 9 2420; 2300
20A/B 80 M 10 2450; 2450
21A/B 88 M 1 2890; 2800
22A/B 38 F 7 2540; 2650
23A/B 71 M 4 2420; 2450
24A/B 89 F 4 2590; 2850
25A/B 82 M 10 2095; 1980
26A/B 83 M 10 2150; 2070
27A/B 90 M 9 2390; 2480
28A/B 59 F 9 2830; 2800
29A/B 90 M 14 2960; 2660
30A/B 81 M 14 2610; 2700
31A/B 64 F 10 2520; 2420
32A/B 81 M 8 3020; 3060
33A/B 84 F 12 2000; 2060
34A/B 62 M 10 2720; 2610
35A/B 86 M 11 2600; 2290
36A/B 82 M 11 2240; 2030
37A/B 83 F 15 2420; 2510
38A/B 74 F 13 2850; 2790
39A/B 81 F 11 2540; 2610
40A/B 73 F 11 2690; 2630
41A/B 60 M 13 2500; 2330
42A/B 52 M 11 2090; 2150
43A/B 69 F 13 2240; 2190
44A/B 53 M 12 2240; 2190
45A/B 73 M 9 2235; 2130
46A/B 59 M 8 2030; 2090
47A/B 68 M 8 2060; 2450
48A/B 55 F 13 2510; 2490
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5 min before extensively rinsing the corneas with fresh saline.
Subsequently 8 mm buttons were trephined from the centre of
each cornea, placed in 48 well plates and covered with absolute
ethanol (500 μl) to extract the retained dye. Aliquots of the
ethanol (2×200 μl) were then removed and placed in 96 well
plates. The optical densities of these solutions weremeasured at
654 nm in a Spectromax spectrophotometer. Corneas of pre-
determined endothelial cell density were treated with sodium
azide (0.1 M in isotonic saline for 16 h) to serve as controls.
Statistical analyses
Data are expressed as mean ± SD. Rate equations for endo-
thelial cell losses were obtained by regression analysis. The
2-tailed Student’s t test for paired data was used to assess
correlative significance.
Results
Hydration levels of and endothelial cell losses from corneas
thinned in MegaCell™MEM with Dextran T500 (5%w/v)
and PEG 10,000 (4 %w/v)
For corneas stored in EB MEM, the extent of deswelling
in 5 % Dextran T500 is achieved using 4 % PEG 10,000
[14]. In this investigation, preliminary experiments indicat-
ed that the hydration levels of 12 pairs of corneas (corneas
1–12, Table 1) stored for 3 weeks in MegaCell™MEM
before transferring to MegaCell™MEM containing either
5 %w/v Dextran T500 or 4 % PEG 10,000 for 14 days were
84.4±1.6 % and 85.0±2.3 % respectively and not signifi-
cantly different (p-value 0.67). Although calculated rates of
endothelial cell loss from these corneas, respectively 38.3±
22.43 and 26.0±9.4 cells per day over 12 days, were also
statistically similar (p-value 0.12), beyond 14 days the en-
dothelia of the 5 % Dextran T500 thinned corneas did not
survive whereas those of corneas thinned with 4 % PEG
10,000 remained morphologically unchanged.
Endothelial cell loss from corneas thinned in MegaCell™DCS
with Dextran T500 (5%w/v), PEG 10,000 (4 %w/v)
and Poloxamer 188 (4 %w/v)
Corneas 13–18 (Table 1) that had been maintained in Mega-
Cell DCS for 3 weeks were transferred to either MegaCell
DCS containing Dextran T500 or MegaCell DCS containing
Table 2 Corneas used for in-
vestigating endothelial cell sur-
vival after storing in EB MEM
and thinning with 5 % Dextran
T500 (a) or in MegaCell DCS
and thinning with 3 % PEG
35,000 (b)




1A/B 86 F 16 35 2090/1885
2A/B 72 M 13 32 2540/2580
3A/B 83 F 10 40 2582/2500
4A/B 33 M 0 40 2376/2418
5A/B 74 F 8 32 2090/1885
6A/B 82 M 8 35 2418/2295
7A/B 86 F 0 39 2746/2705
8A/B 49 F 5 39 2499/2622
9A/B 66 F 14 32 1558/1925
10A/B 81 F 11 32 2335/2663
11A/B 82 M 0 49 2048/2008
12A/B 64 F 0 45 2008/2090
13A/B 41 M 0 47 2171/2211
14A/B 71 F 19 27 2520/2550
15A/B 95 M 16 27 1804/1925
16A/B 75 M 11 27 1970/2008
17A/B 76 F 0 44 2598/2662
18A/B 53 F 28 22 2458/2376
19A/B 63 M 20 27 1722/1683
20A/B 67 M 15 27 2173/2213
21A/B 78 M 11 27 1639/1639
22A/B 66 M 12 22 1232/1188
23A/B 82 F 7 42 2300/1970
24A/B 45 M 4 35 2170/2704
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4 % PEG 10,000 for a period of 6 days. The initial estimated
endothelial cell densities were 2447±256 and 2462±360
cells mm-2 respectively and not significantly different (p-
value 0.76). Over the following 6 days the estimated rate of
cell loss from the corneas held in MegaCell DCS containing
5 % Dextran T500 was negligible and from the corneas held
in MegaCell DCS containing 4 % PEG 10,000, 15 cells mm-
2 per day. The latter set of corneas subsequently thickened
and counting their endothelial cells became increasingly
problematical.
Similar experiments were performed using corneas 19–
24 (Table 1) that after incubation in MegaCell DCS were
transferred to either MegaCell DCS containing 4 % PEG
10,000 or MegaCell DCS containing 4 % Poloxamer 188.
On this occasion the initial ECDs were 2552±179 and 2583
±218 cells mm2 and the respective rates of endothelial cell
losses were 45.5±11.8 and 55.3±26.6 cells per day (p-value
0.48), but again by day 6 all corneas were thickening.
Comparative hydration levels of corneas thinned in EB MEM
5 % Dextran T500 and in MegaCell DCS containing 5 %
Dextran T500, 4 % PEG 10,000 or 4 % Poloxamer P188
Estimated hydration levels of tissue trefined from the centre of
corneas thinned in EB MEM 5 % Dextran T500 or MegaCell
DCS containing 5 % Dextran T500, 4 % PEG 10,000 or 4 %
Poloxamer P188 are given in Table 3. These data indicate that
in MegaCell DCS, the thinning capacities of PEG 10,000 and
Poloxamer P188, at concentrations of 4%w/v, are greater than
5 %w/v Dextran T500. They may also account for the ob-
served time dependent corneal thickening.
Effect of Dextran T500, PEG 10,000 and Poloxamer P188
on the morphology of stromal cells cultured from corneas
held in MegaCell DCS
Previous work showed that explants prepared from corneas
held in MegaCell DCS readily generated both epithelial and
phenotypically uniform, fibroblastic stromal cell cultures if
FCS were added to their incubation medium [11]. Although
this would usually initiate after 1 week, for corneas that had
been thinned, epithelial cell outgrowths were not observed
and stromal cell outgrowth, when and if it occurred, fre-
quently initiated as late as 4 weeks after culturing the
explants. The morphology of these cells was extremely
varied but not necessarily dictated by which thinning
reagent had been used. Examples are shown in Fig. 1a–d.
Confirmation that myofibril differentiation had been in-
duced in many of the cultures as a result of thinning the
corneas was obtained by immunostaining some of the stro-
mal cell cultures with anti α-SMA antibody. Representative
staining patterns are shown in Fig. 1e–h.
Effect of PEG 35,000 concentration on corneal endothelial
cell density, morphology and hydration levels
The observation that MegaCell DCS medium containing
Dextran T500 (5 %w/v), PEG 10,000 (4 %w/v) or Polox-
amer 188 (4 %w/v) induced myofibril formation suggested
that the keratocytes of corneas incubated in these media may
become activated as a result of excessive dehydration.
Table 3 Estimated hydration levels of corneas stored in MegaCell
DCS and thinned in either EB MEM, 5 % Dextran T500, MegaCell
DCS, 4 % PEG 10,000 or MegaCell DCS 4 % Poloxamer 188




EB MEM Dextran T500 5 85.94±1.14
MegaCell DCS, Dextran T500 5 84.90±0.97
MegaCell DCS, PEG 10,000 7 80.71±2.91
MegaCell DCS, Poloxamer 188 7 80.21±3.18
Fig. 1 Morphological variation and anti-SMA antibody staining of
stromal cell outgrowths from corneas held in EB MEM 5 % Dextran
T500 (a, e), MegaCell DCS 5 % Dextran T500 (b, f), MegaCell DCS
4 % PEG 10,000 (c, g), MegaCell DCS 4 % Poloxamer 188 (d, h) for
6 days. Original mag x200
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To address this possibility, corneal pairs 25–48 (Table 1)
that had been maintained in MegaCell DCS for 3 weeks
were transferred to fresh MegaCell DCS containing either 0,
2 %, 3 % or 4 % PEG 35,000. Over a period of 6 days the
endothelia of these corneas was examined microscopically
and their cell densities determined. Subsequently 8 mm
buttons were trefined from the corneal centres for estimating
corneal hydration levels and cell cultures were generated
from the surrounding corneal tissue. The results presented in
Figs 2 and 3 respectively indicated that the inclusion of
PEG 35,000 in MegaCell DCS did not induce endothelial
cell loss and confirmed that the hydration level achieved
in MegaCell DCS containing 4 % PEG 35,000 was
similar to that achieved in 4 % PEG 10,000, significantly
lower than that of corneas incubated in EB MEM con-
taining 5 % Dextran T500. Representative photographs of
the endothelia of corneas incubated in MegaCell DCS
containing 0, 2 %, 3 % or 4 % PEG 35,000 for 6 days
are shown in Fig. 4.
Cell growth from corneas held in MegaCell DCS and
thinned in EB MEM 5 % Dextran T500 or MegaCell DCS
containing 2 %, 3 % and 4 % PEG 35,000
Explants of corneas incubated in Megacell DCS and
MegaCell DCS containing 2 % PEG 35,000 produced
confluent layers of epithelial cells (not shown) 10 days
after culturing. By contrast, explants of the corneas
thinned in EB MEM 5 % Dextran T500 and MegaCell
DCS containing 3 % or 4 % PEG 35,000 produced only
stromal cells. While those of the corneas thinned with
EB MEM 5 % Dextran T500 and 3 % PEG 35,000
appeared to be fibroblasts, significant numbers of those
from corneas thinned with 4 % PEG 35,000 were phe-
notypically myofibroblastic. Although when confluent
these cultures became morphologically similar, when
probed with anti α-SMA antibody, the level of staining
in cultures from corneas thinned with 4 % PEG 35,000
was significantly more intense than in those thinned
with Dextran T500 or 3 % PEG 35,000 (Fig. 5).
Endothelial cell losses from corneas incubated in MegaCell
DCS and EB MEM and respectively thinned in MegaCell
DCS with PEG 35,000 (3 %w/v) or Dextran T500 (5%w/v)
To compare directly the dependence of corneal viability on
culture medium composition, paired corneas 1–10 (Table 2)
were incubated in either MegaCell DCS or EB MEM for
periods ranging from 32 to 40 days in addition to the preincu-
bation period in EB MEM before transferring to either Mega-
Cell DCS containing PEG 35000 (3 %) or EB MEM
containing Dextran T500 for time periods exceeding 20 days.
The estimated rates of endothelial cell losses from these
corneas during storage and in response to the inclusion of


























t = 3 days
t = 6 days
Fig. 2 Endothelial cell
densities of corneas held in
MegaCell DCS containing 2 %,
3 % and 4 %w/v PEG 35,000
for 6 days
























Polyethylene Glycol 35,000 (%)
Fig. 3 Estimated hydration levels of corneas held in MegaCell DCS
containing 2 %, 3 % and 4 %w/v PEG 35,000 for 6 days
1782 Graefes Arch Clin Exp Ophthalmol (2012) 250:1777–1786
These data show that fewer endothelial cells were lost
from the corneas held in MegaCell DCS than from corneas
held in EB MEM (p value<0.001) and, as observed pre-
viously [11], that the preincubation time effects endothelial
cell loss from the latter but not the former set of corneas
(p values 0.002 and 0.53 respectively). They also indicate
that for corneas incubated in MegaCell DCS, the inclusion
of PEG 35,000 for 20 days has no significant effect upon
endothelial cell loss (p value00.076) whereas for corneas
incubated in EB MEM the inclusion of Dextran T500
increases the rate of endothelial cell loss (p value0
0.018). Photographs of the endothelia of corneas (pair 7,
Table 2) that had not been preincubated, are shown in
Fig. 7.
MegaCell DCS   MegaCell DCS   MegaCell DCS  MegaCell DCS
31A - 0             31B - 0              32A - 0                32B - 0
31A - 6 day       31B – 6 day       32A – 6 day       32B – 6 day
MegaCell DCS     +2% PEG 35,000  +3% PEG 35,000  +4% PEG 35,000
Fig. 4 Morphology of the
endothelia of corneas (pairs 31
and 32, Table 1) after
incubation in MegaCell DCS
for 3 weeks (top row) and in
MegaCell DCS and MegaCell
DCS containing 2 %, 3 % and
4 %w/v PEG 35,000 for 6 days
(bottom row)
A1 B1  C1 D1
A2 B2  C2 D2
A3 B3  C3 D3
Fig. 5 Stromal cell cultures derived from corneas held in MegaCell
DCS for 3 weeks then EB MEM 5 % Dextran T500 (a), MegaCell
DCS 5 % Dextran T500 (b), MegaCell DCS 3 % PEG (c) and
MegaCell DCS 4 % PEG (d) for 6 days. Row 1–10 days after culturing
explants. Row 2 - When confluent. Row 3 - When confluent and
immunostained with anti-SMA antibody. Original mag x200
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Janus Green staining
Two additional sets of paired corneas (11–17 and 18–24,
Table 2) were incubated in MegaCell DCS and EB MEM for
a total period of 5–6 weeks before transferring to MegaCell
DCS containing PEG 35,000 (3 %) or EB MEM containing
Dextran T500 (5 %) for 6 days.
The endothelial cell densities of these corneas were mon-
itored. Again the calculated endothelial cell losses (Table 4)
were significantly less in MegaCell DCS and MegaCell
DCS/PEG 35,000 than in EB MEM and EB MEM/Dextran
T500. The results also indicated that over a thinning period
of 6 days the inclusion of PEG 35,000 or Dextran T500 did
not affect significantly the rates of endothelial cell loss in
these media (p values 0.22 and 0.30 respectively). The
corneas were then stained with Janus Green, together with
others for which their endothelial cell densities had been
estimated before placing them in the isotonic saline contain-
ing sodium azide.
Visually, after staining, the endothelia of the azide treated
corneas were almost uniformly dyed whereas on corneas
thinned in MegaCell DCS/PEG 35,000 and EB MEM/
Dextran T500, a few lines of dye tracked radially inwards
from the limbus but generally remained in the peripheral
region.
The best fit relationship between endothelial cell density
and OD654 of the Janus Green dye extracted after killing
these cells with sodium azide was polynomial (Fig. 8) and
the levels of staining on the MegaCell DCS/PEG 35,000 and
EB MEM/Dextran T500 thinned corneas were 0.15±0.03
and 0.16±0.06 respectively and statistically similar (p value
0.47). Although it was not possible to relate these readings
to the densities of dead endothelial cells because they fell
well below the calibration limits, given the staining patterns
it was considered likely that the stain picked out areas of cell
loss/exposed Descemets membrane [13].
Discussion
MEM with Earles salts, Hepes and supplemented with gluta-
mine, antibiotics and foetal calf serum (EB MEM) was the
culture medium originally chosen to store corneas. Together
with the Dextran T500 used for thinning the corneas prior to
transplantation it is still widely used in European Eye Banks.
Although EB MEM is adequate for the purpose of storing
corneas, the failures of this holding system over prolonged
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Fig. 6 Rates of endothelial cell loss from corneas maintained in EB
MEM and MegaCell DCS and respectively thinned with 5 % Dextran
T500 and 3 % PEG 35,000
A 0                        A 39days             A 39 +10 days         A 39+ 20days
B 0                        B 39days             B 39 +10 days         B 39+ 20days
Fig. 7 Endothelial morphology
of corneas (pair 7, Table 2)
maintained in EB MEM (a) and
MegaCell DCS (b) over
39 days and respectively
thinned with 5 % Dextran T500
and 3 % PEG 35,000 for 10 and
20 days
Table 4 Rates of endo-
thelial cell loss from
corneas maintained in
EB MEM (A) or Mega-
Cell DCS (B) and
thinned respectively
with Dextran T500 and
PEG 35,000




A corneas 25.4±8.7 29.7±18.6
B corneas 7.0±4.9 5.3±4.2
Set 2 (n07)
A corneas 22.2±11.2 36.6±38.8
B corneas 10.0±10.0 17.4±10.2
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poor buffering capacity and, additionally, unless the added FCS
concentration is increased from the traditionally used 2 % to
around 10%, the corneas deteriorate significantly after 3 weeks
in culture [15]. This measure, however, ceased to be an option
since the outbreak of bovine spongiform encephalopathy (BSE)
in the UK and regulatory bodies desired the use of media that
do not require the addition of serum to sustain the tissue.
In response to this, MegaCell DCS was formulated for
storing corneas prior to transplantation. In contrast to the fate
of corneas maintained in EBMEM, those maintained in Mega-
Cell DCS do not deteriorate after 3 weeks in culture. Further-
more, although this animal product-free medium does not
support cell proliferation, after prolonged storage periods, cor-
neal epithelial and stromal cells remain viable and will prolif-
erate once foetal calf serum has been added to the medium [11].
The use of MegaCell DCS does not prevent corneas
swelling when cultured and hence preclude the necessity
of reversing this process prior to transplant.
The practice of using highmolecular weight polysaccharides
for dehydrating tissues is well understood and Dextran T500
became the polymer of choice for thinning organ cultured
corneas prior to transplant because, with a molecular weight
of 500,000, it would not be expected to penetrate tissues and
cells. Despite this it does [3–5] and the reason probably relates
to a high level of polydispersity [16]. For this reason and
because solutions of Dextran T500 are not easy to prepare, an
alternative for using with MegaCell DCS was sought.
Preliminary experiments carried out using corneas held in
MegaCell™MEM and transferred to the same medium con-
taining 4 % PEG 10,000 indicated that this polymer would thin
them with minimal endothelial cell loss over a 14 day period.
However, when this culture medium was replaced with Mega-
Cell DCS problems, unrelated to endothelial viability as judged
by the lack of trypan blue staining, became apparent. The
polymers initially included in theMegaCell DCS were Dextran
T500 (5 %), PEG 10,000 (4 %) and Poloxamer 188 (4 %)
which is considered better than Dextran T500 for deswelling
corneas [17], has been patented for this usage [6] and is one of a
series of synthetic amphiphilic aqueous gels, marketed as Plur-
onics (BASF Chemical Company Ltd) and patented for use in
the Pharmaceutical Industry in 1973. In all cases the corneas
became microscopically opaque after 6 days, were excessively
dehydrated and difficult to generate cell cultures from. Stromal
cells that eventually grew out of explants were of mixed mor-
phology and included myofibroblasts.
In culture, corneal stromal cells treated with TGF-β differ-
entiate into myofibroblasts [18, 19]. In vivo, the transformation
of fibroblasts into myofibroblasts is a known consequence of
trauma, associated with corneal haze and linked to wound
healing [20, 21]. Given that explants of corneas maintained
for prolonged periods in MegaCell DCS readily produce ho-
mogeneous cultures of fibroblastic stromal cells, keratocyte
activation in corneas subsequently thinned for 6 days with
5 % Dextran T500, 4 % PEG or 4 % Poloxamer 188 possibly
relates to excessive dehydration. When Poloxamer 188 was
judged to be superior to Dextran T500 for deswelling corneas
in an animal compound-free medium [6] its concentration was
not given. Subsequently, when comparing the toxicities of a
number of poloxamers in CorneaMax (Eurobio, Les Ulys,
France), the stated concentration of Poloxamer 188, used to
achieve a standardised osmolality, was 3 %w/v [17].
In addition to over-dehydration, however, polymer uptake
may also contribute to changes in keratocyte physiology. That
this is possible relates to observations that explants of corneas
incubated in EB MEM with 5 % Dextran T500 also produce
myofibroblasts. Additionally, the polydispersity of PEG is sig-
nificantly less than Dextran T500 and although corneas thinned
with 4 % PEG 10,000 became microscopically opaque after
6 days, those thinned with 4 % PEG 35,000 remained clear.
Retrospectively it was realised that the influence of Mega-
Cell DCS over the corneal thinning process possibly related to
the fact that it contains 4.5x more glucose than MegaCell
MEM or EB MEM. In investigating this, it was found that
the hydration level achieved using 5 % Dextran T500 in EB
MEM was matched by concentrations of 3 % PEG 35,000 in
MegaCell DCS and significantly less in MegaCell DCS con-
taining 4 % PEG 35,000. In addition, when confluent, stromal
cell cultures prepared from corneas thinned in 4 % PEG
35,000 retained high levels of anti α-SMA antibody staining
relative to those thinned in Dextran T500 and 3 % PEG
35,000. This observation indicates that there could be post-
transplantation consequences to the metabolic status of stro-
mal cells: Myofibroblasts present in grafted corneas may
undergo IL-1 induced apoptosis [18], but if persistent, secrete
the complement of collagens and proteoglycans characteristic
of scar tissue and cause corneal haze [20, 22].
Polyethylene glycol, used at a concentration of 3 %(w/v) in
MegaCell DCSwas, therefore, considered to be the polymer of
choice for thinning corneas: In contrast to the corneas thinned
with Dextran T500, even after 20 days in the presence of this
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Fig. 8 Relationship between Janus Green dye uptake and the ECD of
corneas subsequently treated with 0.1 M sodium azide
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reagent they appeared healthy, their endothelial cell mosaic
was morphologically regular and there was little reduction in
density. However, to confirm that these cells remained viable,
Janus Green was employed. This is a vital dye that is soluble in
saline, binds nuclear and cytoplasmic components of dead cells
and once bound can be released from the tissue with ethanol.
Although unsuitable for checking the suitability of corneas
destined for transplantation it has been used to assess corneal
endothelium viability for experimental purposes: Because both
dead endothelial cells and Descemet’s membrane in areas of
cell loss are equally stained [13], the overall extent of damage
can be determined.
In an attempt to use Janus Green to quantify the numbers of
dead endothelial cells on corneas that had been either main-
tained in MegaCell DCS and thinned in MegaCell DCS con-
taining PEG 35,000 or maintained in EB MEM and thinned in
EBMEMcontaining Dextran T500, it was found that there was
a polynomial relationship between dead endothelial cell density
and the optical density of the ethanolic solution of dye extracted
from the tissue. It was also found that the extent of staining on
the endothelia of the corneas thinned in MegaCell DCS/PEG
35,000 and EB MEM/Dextran T500 for 6 days was similar.
Visual examination of the corneas after staining indicated that
the dye was primarily located in folds, tracking inwards from
the limbus. Thus, although the area of endothelial damage may
be the same on both sets of corneas, the numbers of viable
endothelial cells remaining on the corneas maintained inMega-
Cell DCS and thinned in MegaCell DCS/PEG 35,000 were
significantly higher than those on the corneas maintained in EB
MEM and thinned in EB MEM/Dextran T500.
In summary, PEG 35,000 included at a concentration of 3 %
w/v, is the polymer of choice for returning corneas maintained
in MegaCell DCS to physiological hydration levels prior to
transplantation. It is non toxic to the corneal endothelium and
does not induce corneal endothelial cell loss.
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